13959611000001108: Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)
\UK product\Virtual medicinal product\Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug)\Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Azelastine\Product containing only azelastine in nasal dose form (medicinal product form)\Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug)\Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Azelastine\Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug)\Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)
\UK product\Trade family\Rhinolast\Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing histamine receptor antagonist\Product containing histamine H1 receptor antagonist\Product containing azelastine\Azelastine\Product containing only azelastine in nasal dose form (medicinal product form)\Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug)\Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing histamine receptor antagonist\Product containing histamine H1 receptor antagonist\Product containing azelastine\Azelastine\Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug)\Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing histamine receptor antagonist\Product containing histamine H1 receptor antagonist\Product containing azelastine\Product containing azelastine in nasal dose form (medicinal product form)\Product containing only azelastine in nasal dose form (medicinal product form)\Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug)\Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing histamine receptor antagonist\Product containing phthalazinone derivative\Product containing azelastine\Azelastine\Product containing only azelastine in nasal dose form (medicinal product form)\Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug)\Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing histamine receptor antagonist\Product containing phthalazinone derivative\Product containing azelastine\Azelastine\Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug)\Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing histamine receptor antagonist\Product containing phthalazinone derivative\Product containing azelastine\Product containing azelastine in nasal dose form (medicinal product form)\Product containing only azelastine in nasal dose form (medicinal product form)\Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug)\Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Product manufactured as nasal dose form\Product containing azelastine in nasal dose form (medicinal product form)\Product containing only azelastine in nasal dose form (medicinal product form)\Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug)\Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

49931201000001110 Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

78194901000001119 Rhinolast 140micrograms/dose nasal spray (DE Pharmaceuticals) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) parallel import indicator	Parallel Import - supplier (qualifier value)	false	Inferred relationship	Existential restriction modifier
Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) parallel import indicator	Parallel import	true	Inferred relationship	Existential restriction modifier
Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)	Is a	Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug)	true	Inferred relationship	Existential restriction modifier
Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)	Has active ingredient	Azelastine hydrochloride	false	Inferred relationship	Existential restriction modifier
Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)	Has manufactured dose form	Nasal dose form	true	Inferred relationship	Existential restriction modifier
Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)	Has manufactured dose form	Spray dose form	false	Inferred relationship	Existential restriction modifier
Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)	Is a	Rhinolast	true	Inferred relationship	Existential restriction modifier
Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)	Has specific active ingredient	Azelastine hydrochloride	true	Inferred relationship	Existential restriction modifier
Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)	Has dispensed dose form	Spray dose form	true	Inferred relationship	Existential restriction modifier
Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd) 20 ml	Is pack of	False	Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier
Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd) 22 ml	Is pack of	False	Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier
Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd) 20 ml	Has AMP	True	Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier
Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd) 22 ml	Has AMP	True	Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
49931201000001110	Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
78194901000001119	Rhinolast 140micrograms/dose nasal spray (DE Pharmaceuticals)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module